Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study-FLORA.
Douma LH, Hofman MM, Zwierenga F, Zondervan TMT, Buma AIG, Schouwink H, Dumoulin DW, Burgers JA, Smesseim I, Aerts JGJV, de Gooijer CJ. Douma LH, et al. Among authors: smesseim i. ESMO Open. 2025 Jan 21;10(2):104123. doi: 10.1016/j.esmoop.2024.104123. Online ahead of print. ESMO Open. 2025. PMID: 39842244 Free article.
Artificial Intelligence-based Quantification of Pleural Plaque Volume and Association With Lung Function in Asbestos-exposed Patients.
Groot Lipman KBW, Boellaard TN, de Gooijer CJ, Bogveradze N, Hong EK, Landolfi F, Castagnoli F, Vakhidova N, Smesseim I, van der Heijden F, Beets-Tan RGH, Wittenberg R, Bodalal Z, Burgers JA, Trebeschi S. Groot Lipman KBW, et al. Among authors: smesseim i. J Thorac Imaging. 2024 May 1;39(3):165-172. doi: 10.1097/RTI.0000000000000759. Epub 2023 Nov 1. J Thorac Imaging. 2024. PMID: 37905941 Free PMC article.
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study.
Douma LH, Lalezari F, van der Noort V, de Vries JF, Monkhorst K, Smesseim I, Baas P, Schilder B, Vermeulen M, Burgers JA, de Gooijer CJ. Douma LH, et al. Among authors: smesseim i. Lancet Oncol. 2023 Nov;24(11):1219-1228. doi: 10.1016/S1470-2045(23)00446-1. Epub 2023 Oct 13. Lancet Oncol. 2023. PMID: 37844598 Clinical Trial.
16 results